Loading... Please wait... Loading... Please wait...
ESTIMATED
11/10/2022
11/10/2022
(AS OF MARCH 31)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | $1.58 | $1.58 | $1.58 |
| Q2 2024 | 0 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 0 | $1.54 | $1.54 | $1.54 |
Viveve Medical, Inc. last posted its earnings results on Thursday, November 10th, 2022. The company reported $-0.59 earnings per share for the quarter, topping analysts' consensus estimates of $-0.66 by $0.07. The company had revenue of 1.68 M for the quarter and had revenue of 6.43 M for the year. Viveve Medical, Inc. has generated $-2 earnings per share over the last year ($-2.26 diluted earnings per share) and currently has a price-to-earnings ratio of -0. Viveve Medical, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 2nd, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 11/10/2022 | Q3 2022 | -$0.66 | -$0.50 | 0.16 | $1.81 M | $1.68 M | 08/11/2022 | Q2 2022 | -$0.67 | -$0.58 | 0.09 | $1.17 M | $1.80 M | 05/12/2022 | Q1 2022 | -$0.67 | -$0.58 | 0.09 | $1.64 M | 03/17/2022 | Q4 2021 | -$0.59 | -$0.63 | -0.04 | $1.71 M | 11/12/2021 | Q3 2021 | -$0.55 | $1.94 M | $1.62 M | 08/12/2021 | Q2 2021 | -$0.65 | -$0.39 | 0.26 | $921,807 | $1.65 M | 05/13/2021 | Q1 2021 | -$0.51 | -$0.67 | -0.16 | $1.45 M | 03/18/2021 | Q4 2020 | -$2.59 | -$2.19 | 0.4 | $1.95 M | 11/12/2020 | Q3 2020 | -$0.53 | -$2.07 | -1.54 | $2.07 M | $1.52 M | 08/13/2020 | Q2 2020 | -$0.59 | -$5.02 | -4.43 | $728,701 | $704,000 | 05/14/2020 | Q1 2020 | -$12.60 | -$7.07 | 5.53 | $1.30 M | 03/19/2020 | Q4 2019 | -$12.40 | -$20.94 | -8.54 | $1.45 M | 11/07/2019 | Q3 2019 | -$16.00 | -$135.08 | -119.08 | $1.25 M | $1.05 M | 08/08/2019 | Q2 2019 | -$180.00 | -$209.28 | -29.28 | $893,198 | $1.05 M | 05/09/2019 | Q1 2019 | -$300.00 | -$216.28 | 83.72 | $3.01 M | 03/15/2019 | Q4 2018 | -$380.23 | $4.47 M | 11/08/2018 | Q3 2018 | -$330.00 | -$390.74 | -60.74 | $4.13 M | $4.82 M | 08/09/2018 | Q2 2018 | -$390.00 | -$367.86 | 22.14 | $5.64 M | $5.53 M | 05/10/2018 | Q1 2018 | -$400.00 | -$490.17 | -90.17 | $3.70 M | 03/16/2018 | Q4 2017 | -$526.06 | $5.10 M |
|---|
A. Viveve Medical, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 2nd, 2024 based off last year's report dates.
A. In the previous quarter, Viveve Medical, Inc. (NASDAQ:VIVE) reported $-0.59 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.66 by $0.07.
A. The conference call for Viveve Medical, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Viveve Medical, Inc.'s latest earnings report can be read online.
A. Viveve Medical, Inc. (NASDAQ:VIVE) has a recorded annual revenue of $6.43 M.
A. Viveve Medical, Inc. (NASDAQ:VIVE) has a recorded net income of $6.43 M. Viveve Medical, Inc. has generated $-2.26 earnings per share over the last four quarters.
A. Viveve Medical, Inc. (NASDAQ:VIVE) has a price-to-earnings ratio of -0 and price/earnings-to-growth ratio is -0.
